Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
The findings underscore crucial role of vaccines in preventing extreme outcomes among Covid patients and allays doubts around vaccine efficacy, especially with respect to delta variant.
The study, however, said the flu vaccine did not lessen chances of death from Covid and warned that flu shots can not be a replacement for Covid vaccines.
The findings were revealed at the Alzheimer’s Association International Conference and the American Heart Association’s Basic Cardiovascular Sciences 2020 Scientific Sessions.
French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS